EagleClaw Capital Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,880
| Closed | -$229K | – | 147 |
|
|
2025
Q4 | $229K | Buy |
+2,880
| New | +$227K | 0.03% | 139 |
|
|
2025
Q2 | – | Sell |
-4,135
| Closed | -$280K | – | 146 |
|
|
2025
Q1 | $280K | Sell |
4,135
-2,000
| -33% | -$120K | 0.04% | 129 |
|
|
2024
Q4 | $275K | Buy |
6,135
+200
| +3% | +$11.2K | 0.04% | 126 |
|
|
2024
Q3 | $373K | Sell |
5,935
-3,350
| -36% | -$195K | 0.06% | 112 |
|
|
2024
Q2 | $548K | Sell |
9,285
-725
| -7% | -$45.4K | 0.1% | 99 |
|
|
2024
Q1 | $798K | Sell |
10,010
-2,175
| -18% | -$166K | 0.14% | 91 |
|
|
2023
Q4 | $962K | Sell |
12,185
-1,176
| -9% | -$83.7K | 0.2% | 85 |
|
|
2023
Q3 | $933K | Sell |
13,361
-251
| -2% | -$17.8K | 0.21% | 82 |
|
|
2023
Q2 | $941K | Sell |
13,612
-5,825
| -30% | -$414K | 0.22% | 81 |
|
|
2023
Q1 | $1.44M | Sell |
19,437
-3,375
| -15% | -$283K | 0.34% | 73 |
|
|
2022
Q4 | $2.13M | Sell |
22,812
-800
| -3% | -$77.2K | 0.51% | 65 |
|
|
2022
Q3 | $2.25M | Sell |
23,612
-300
| -1% | -$29.7K | 0.63% | 55 |
|
|
2022
Q2 | $2.22M | Sell |
23,912
-25
| -0.1% | -$2.44K | 0.6% | 56 |
|
|
2022
Q1 | $2.42M | Sell |
23,937
-3,975
| -14% | -$418K | 0.56% | 56 |
|
|
2021
Q4 | $2.88M | Sell |
27,912
-1,075
| -4% | -$99.3K | 0.63% | 47 |
|
|
2021
Q3 | $2.45M | Sell |
28,987
-125
| -0.4% | -$10.5K | 0.63% | 55 |
|
|
2021
Q2 | $2.43M | Buy |
29,112
+925
| +3% | +$75.8K | 0.63% | 52 |
|
|
2021
Q1 | $2.13M | Buy |
28,187
+584
| +2% | +$42.5K | 0.61% | 53 |
|
|
2020
Q4 | $1.88M | Sell |
27,603
-3,813
| -12% | -$248K | 0.6% | 54 |
|
|
2020
Q3 | $1.83M | Buy |
31,416
+600
| +2% | +$37.3K | 0.64% | 51 |
|
|
2020
Q2 | $1.99M | Hold |
30,816
| – | – | 0.77% | 45 |
|
|
2020
Q1 | $1.83M | Buy |
30,816
+25
| +0.1% | +$1.67K | 0.86% | 41 |
|
|
2019
Q4 | $2.28M | Sell |
30,791
-390
| -1% | -$27.4K | 0.83% | 42 |
|
|
2019
Q3 | $1.97M | Buy |
31,181
+59
| +0.2% | +$3.5K | 0.8% | 39 |
|
|
2019
Q2 | $1.69M | Sell |
31,122
-3,316
| -10% | -$179K | 0.73% | 46 |
|
|
2019
Q1 | $1.85M | Buy |
34,438
+825
| +2% | +$50.9K | 0.85% | 38 |
|
|
2018
Q4 | $2.21M | Buy |
33,613
+1,604
| +5% | +$120K | 1.16% | 24 |
|
|
2018
Q3 | $2.53M | Sell |
32,009
-167
| -0.5% | -$11.9K | 1.11% | 25 |
|
|
2018
Q2 | $2.06M | Sell |
32,176
-150
| -0.5% | -$9.88K | 1% | 30 |
|
|
2018
Q1 | $2.01M | Buy |
32,326
+100
| +0.3% | +$7.17K | 1.02% | 30 |
|
|
2017
Q4 | $2.34M | Buy |
32,226
+810
| +3% | +$58.9K | 1.18% | 29 |
|
|
2017
Q3 | $2.55M | Sell |
31,416
-1,025
| -3% | -$81.1K | 1.44% | 22 |
|
|
2017
Q2 | $2.6M | Sell |
32,441
-250
| -0.8% | -$19.7K | 1.53% | 20 |
|
|
2017
Q1 | $2.58M | Buy |
32,691
+600
| +2% | +$47.9K | 1.55% | 21 |
|
|
2016
Q4 | $2.54M | Sell |
32,091
-1,100
| -3% | -$89K | 1.6% | 20 |
|
|
2016
Q3 | $2.95M | Buy |
33,191
+550
| +2% | +$51.9K | 1.89% | 15 |
|
|
2016
Q2 | $3.13M | Buy |
32,641
+725
| +2% | +$72.3K | 2.08% | 10 |
|
|
2016
Q1 | $3.31M | Sell |
31,916
-250
| -0.8% | -$24.3K | 2.24% | 8 |
|
|
2015
Q4 | $3.14M | Buy |
32,166
+4,525
| +16% | +$443K | 2.09% | 10 |
|
|
2015
Q3 | $2.66M | Sell |
27,641
-1,200
| -4% | -$126K | 1.87% | 13 |
|
|
2015
Q2 | $3.02M | Buy |
28,841
+8,330
| +41% | +$851K | 1.93% | 12 |
|
|
2015
Q1 | $2.12M | Buy |
20,511
+125
| +0.6% | +$12.6K | 1.37% | 29 |
|
|
2014
Q4 | $1.96M | Sell |
20,386
-308
| -1% | -$27.1K | 1.3% | 30 |
|
|
2014
Q3 | $1.65M | Sell |
20,694
-225
| -1% | -$17.7K | 1.12% | 37 |
|
|
2014
Q2 | $1.58M | Buy |
20,919
+2,300
| +12% | +$174K | 1.07% | 39 |
|
|
2014
Q1 | $1.39M | Buy |
+18,619
| New | +$1.32M | 1.01% | 41 |
|
Other funds holding CVS
VCM
VPM
